Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Lofexidine		Hospital only
Lomitapide		Homozygous familial hypercholesterolaemia - hospital only
Loperamide capsules		Capsules are more cost effective than tablets
Loperamide instant melts®		Restricted to high output stoma patients
Lotriderm® cream		Potent
Lumacaftor-ivacaftor (Orkambi®)	TA398 - Lumacaftor-ivacaftor for treating cystic fibrosis homozygous for the F508del mutation	NHSE commissioning statement
Lysine acetylsalicylate injection		Interventional neuroradiology only
Magnesium glycerophosphate		Unlicensed – specialist initiation and stabilisation. Under review.
Manchester bleaching cream		Unlicensed special
Mannitol infusion		Hospital only

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.